Related content

Anti-Cyclic Citrullinated Peptide Antibody-Positive Meningoencephalitis in the Preclinical Period of Rheumatoid Arthritis

By  

Case Reports in Neurology, Vol. 8, Iss. 2, 2016-07 ,pp. : 156-160

Karger

Access to resources Recommend Favorite

Citrulline and anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis

By Yamada Ryo   Suzuki Akari   Yamamoto Kazuhiko  

Future Rheumatology, Vol. 1, Iss. 2, 2006-04 ,pp. : 249-258

Future Medicine

Access to resources Recommend Favorite

Decrease in the levels of anti-cyclic citrullinated peptide antibody in Japanese patients with rheumatoid arthritis who responded to anti-tumor necrosis factor-α

By Onishi Sachiko   Yoshio Taku   Nagashima Takao   Minota Seiji  

Modern Rheumatology, Vol. 20, Iss. 5, 2010-10 ,pp. : 528-530

Springer Publishing Company

Access to resources Recommend Favorite

Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis

By Grootenboer-Mignot S   Nicaise-Roland P   Delaunay C   Meyer O   Chollet-Martin S   Labarre C  

Scandinavian Journal of Rheumatology, Vol. 33, Iss. 4, 2004-07 ,pp. : 218-220

Informa Healthcare

Access to resources Recommend Favorite

Anti-cyclic citrullinated peptide antibodies do not reflect self-reported disability and physical health in patients with rheumatoid arthritis of less than 5 years of duration

By Poulsen Chalotte   Jacobsen Søren   Frisch Morten   Frederiksen Kirsten   Johansen Christoffer  

Rheumatology International, Vol. 33, Iss. 11, 2013-11 ,pp. : 2763-2772

Springer Publishing Company

Access to resources Recommend Favorite